Bank of New Hampshire Has $976,000 Stock Holdings in Danaher Co. (NYSE:DHR)

Bank of New Hampshire decreased its holdings in shares of Danaher Co. (NYSE:DHR) by 3.2% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,763 shares of the conglomerate’s stock after selling 158 shares during the quarter. Bank of New Hampshire’s holdings in Danaher were worth $976,000 at the end of the most recent reporting period.

Several other hedge funds have also added to or reduced their stakes in DHR. Heck Capital Advisors LLC acquired a new stake in shares of Danaher during the fourth quarter worth $27,000. Golden State Wealth Management LLC acquired a new stake in shares of Danaher during the fourth quarter worth $31,000. Hurley Capital LLC acquired a new stake in shares of Danaher during the fourth quarter worth $34,000. Pineridge Advisors LLC lifted its holdings in shares of Danaher by 63.3% during the fourth quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock worth $34,000 after buying an additional 57 shares in the last quarter. Finally, Rialto Wealth Management LLC acquired a new stake in shares of Danaher during the fourth quarter worth $34,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on DHR shares. Guggenheim reissued a “buy” rating and set a $250.00 target price on shares of Danaher in a report on Wednesday, April 23rd. HSBC dropped their target price on Danaher from $270.00 to $240.00 in a report on Friday, April 25th. Barclays raised their price target on Danaher from $205.00 to $215.00 and gave the stock an “overweight” rating in a research report on Tuesday, April 22nd. Citigroup restated a “buy” rating on shares of Danaher in a research report on Monday, April 7th. Finally, Royal Bank of Canada restated an “outperform” rating and issued a $250.00 price target on shares of Danaher in a research report on Wednesday, April 23rd. Four investment analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the company. According to data from MarketBeat, Danaher currently has an average rating of “Moderate Buy” and a consensus price target of $263.24.

Danaher Stock Performance

Danaher stock opened at $196.13 on Friday. Danaher Co. has a 12-month low of $171.00 and a 12-month high of $281.70. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. The business’s 50-day moving average price is $191.34 and its two-hundred day moving average price is $212.19. The stock has a market cap of $140.36 billion, a PE ratio of 37.15, a P/E/G ratio of 2.66 and a beta of 0.77.

Danaher (NYSE:DHR) last released its earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.62 by $0.26. Danaher had a return on equity of 10.82% and a net margin of 16.33%. The firm had revenue of $5.74 billion for the quarter, compared to analysts’ expectations of $5.58 billion. As a group, analysts expect that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be given a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a yield of 0.65%. Danaher’s dividend payout ratio is presently 24.85%.

Insider Transactions at Danaher

In other news, EVP Christopher Paul Riley sold 15,805 shares of the business’s stock in a transaction dated Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the sale, the executive vice president now directly owns 15,179 shares in the company, valued at approximately $3,005,442. The trade was a 51.01% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Chairman Steven M. Rales sold 1,250,000 shares of the business’s stock in a transaction dated Monday, May 12th. The stock was sold at an average price of $196.74, for a total value of $245,925,000.00. Following the sale, the chairman now owns 3,105,808 shares in the company, valued at approximately $611,036,665.92. This trade represents a 28.70% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 11.10% of the company’s stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.